Rigel Pharmaceuticals Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · South San Francisco, CA
RIGL chart
What traders are saying about $RIGL
Latest postsRigel Pharmaceuticals Inc news
- Arvinas to Report Third Quarter 2026 Financial Results on November 3, 2026
StreetInsider ·
- (RIGL) Price Dynamics and Execution-Aware Positioning
Stock Traders Daily ·
- Rigel Pharmaceuticals, Inc. (RIGL) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Rigel Pharmaceuticals, Inc. (RIGL) stock price, news, quote and history
Yahoo Finance Singapore ·
- Rigel Pharmaceuticals, Inc. Estimates – NASDAQ:RIGL
TradingView ·
- Rigel Pharmaceuticals Shares Rose Even As Profit Fell
Yahoo Finance ·
- Rigel Pharmaceuticals shifts focus to oncology with new product VEPPANU targeting $1B breast cancer market.
Pluang ·
- Rigel Pharmaceuticals: Turning Big Pharma's Castoffs Into A Growth Engine (NASDAQ:RIGL)
Seeking Alpha ·
- Rigel Highlights New GAVRETO® (pralsetinib) Data Across RET Fusion-Positive Cancers in Oral and Poster Presentations at ESMO Congress 2026
Yahoo Finance ·
- Reasons Why Investors Should Consider Betting on Arvinas Stock
Yahoo Finance ·
- Knight Therapeutics Announces Launch of TAVALISSE® in Brazil
Yahoo Finance ·
- Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Yahoo Finance ·
Rigel Pharmaceuticals Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $294.3M | $179.3M | $116.9M | $120.2M |
| Net income | $367.0M | $17.5M | -$25.1M | -$58.6M |
| Diluted EPS | $19.48 | $0.99 | $-1.44 | $-3.44 |
| Total assets (year end) | $513.6M | $164.0M | $117.2M | $134.3M |
| Cash and equivalents (year end) | $40.6M | $56.7M | $32.8M | $24.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Rigel Pharmaceuticals Inc
- Ticker
- RIGL (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1034842
- Former names
- RIGEL PHARMACEUTICALS INC
Frequently asked questions
What exchange is Rigel Pharmaceuticals Inc listed on?
Rigel Pharmaceuticals Inc trades on the Nasdaq under the ticker symbol RIGL.
What industry is Rigel Pharmaceuticals Inc in?
Rigel Pharmaceuticals Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Rigel Pharmaceuticals Inc headquartered?
Rigel Pharmaceuticals Inc's business address on file with the SEC is in South San Francisco, CA.
When does Rigel Pharmaceuticals Inc's fiscal year end?
Rigel Pharmaceuticals Inc's fiscal year ends on December 31.
How much revenue did Rigel Pharmaceuticals Inc report?
Rigel Pharmaceuticals Inc reported $294.3M in revenue for calendar year 2025, according to its SEC filings.